Accenture (NYSE:ACN) has a market capitalization of $41.22 billion. The company employs 244,000 people, generates revenue of $27,352.91 million and has a net income of $2,553.24 million. The firm’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $3,983.71 million. The EBITDA margin is 14.56 percent (operating margin 12.69 percent and net profit margin 9.33 percent).
Financial Analysis: The total debt represents 0.03 percent of the company’s assets and the total debt in relation to the equity amounts to 0.11 percent. Due to the financial situation, a return on equity of 67.84 percent was realized. Twelve trailing months earnings per share reached a value of $3.87. Last fiscal year, the company paid $0.90 in form of dividends to shareholders. The earnings per share are expected to grow by 10.43 percent for the next five years.
Market Valuation: Here are the price ratios of the company: The P/E ratio is 15.65, P/S ratio 1.53 and P/B ratio 10.75. Dividend Yield: 2.24 percent. The beta ratio is 0.85.
| Long-Term Stock History Chart Of Accenture (Click to enlarge) |
| Long-Term Dividends History of Accenture (ACN) (Click to enlarge) |
| Long-Term Dividend Yield History of Accenture (NYSE: ACN) (Click to enlarge) |
Novo Nordisk (NYSE:NVO) has a market capitalization of $103.24 billion. The company employs 32,136 people, generates revenue of $11,044.78 million and has a net income of $2,846.18 million. The firm’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $4,139.17 million. The EBITDA margin is 37.48 percent (operating margin 33.72 percent and net profit margin 25.77 percent).
Financial Analysis: The total debt represents 1.32 percent of the company’s assets and the total debt in relation to the equity amounts to 2.28 percent. Due to the financial situation, a return on equity of 45.95 percent was realized. Twelve trailing months earnings per share reached a value of $5.00. Last fiscal year, the company paid $2.33 in form of dividends to shareholders.The earnings per share are expected to grow by 15.30 percent for the next five years.
Market Valuation: Here are the price ratios of the company: The P/E ratio is 31.46, P/S ratio 6.42 and P/B ratio 14.16. Dividend Yield: 1.61 percent. The beta ratio is 0.56.
| Long-Term Stock History Chart Of Novo Nordisk (Click to enlarge) |
| Long-Term Dividends History of Novo Nordisk (NVO) (Click to enlarge) |
| Long-Term Dividend Yield History of Novo Nordisk (NYSE: NVO) (Click to enlarge) |
Tim Hortons (NYSE:THI) has a market capitalization of $8.28 billion. The company employs 2,288 people, generates revenue of $2,850.12 million and has a net income of $385.36 million. The firm’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $670.32 million. The EBITDA margin is 23.52 percent (operating margin 19.96 percent and net profit margin 13.52 percent).
Financial Analysis: The total debt represents 23.44 percent of the company’s assets and the total debt in relation to the equity amounts to 44.83 percent. Due to the financial situation, a return on equity of 29.57 percent was realized. Twelve trailing months earnings per share reached a value of $2.44. Last fiscal year, the company paid $0.68 in form of dividends to shareholders. The earnings per share are expected to grow by 13.30 percent for the next five years.
Market Valuation: Here are the price ratios of the company: The P/E ratio is 21.76, P/S ratio 2.90 and P/B ratio 7.35. Dividend Yield: 1.54 percent. The beta ratio is 0.72.
| Long-Term Stock History Chart Of Tim Hortons (Click to enlarge) |
| Long-Term Dividends History of Tim Hortons (THI) (Click to enlarge) |
| Long-Term Dividend Yield History of Tim Hortons (NYSE: THI) (Click to enlarge) |

No comments:
Post a Comment
Do you have any questions or notes to this article?
Please let me know your thoughts and we will discuss it.